Nalaganje...
Design and rationale of the non-interventional, edoxaban treatment in routiNe clinical prActice in patients with venous ThromboEmbolism in Europe (ETNA-VTE-Europe) study
BACKGROUND: Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) has an annual incidence rate of 104–183 per 100,000 person-years. After a VTE episode, the two-year recurrence rate is about 17%. Consequently, effective and safe anticoagulation is paramount....
Shranjeno v:
izdano v: | Thromb J |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2018
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5928573/ https://ncbi.nlm.nih.gov/pubmed/29719492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-018-0163-7 |
Oznake: |
Označite
Brez oznak, prvi označite!
|